https://cohostpodcasting.com <![CDATA[Illumanations: The Future of Healthcare]]> en e5d910dc-7e35-489d-8853-0cfa576ac68a Wed, 28 Aug 2024 08:28:07 -0400 Thu, 28 May 2026 07:43:03 -0400 https://www.lumagroup.com/ <![CDATA[Illumanations: The Future of Healthcare]]> https://files.cohostpodcasting.com/quill-file-prod/360a6f24-a4da-457f-8268-f548b6aff012/shows/e5d910dc-7e35-489d-8853-0cfa576ac68a/cover-art/original_4a9462862db50a8306e73a12547b1866.jpg https://www.lumagroup.com/ episodic false https://feeds.cohostpodcasting.com/nwCDpSmS brittany@quillit.io <![CDATA[ Delivering on the Promise of Precision Medicine: A Conversation with Dr. Allison Hulme]]> In this episode, Dr. Themasap Khan sits down with Aeovian Pharmaceuticals' President

and CEO, Dr. Allison Hulme to discuss how she found herself in the pharma

space, what's ahead for Aeovian, and why the work they are doing is so

important for a population with an incredibly high unmet need. We are also

excited to welcome Aeovian and the full team to Luma Group as our most recent

investment (December 2025).

]]> Mon, 09 Feb 2026 12:00:00 -0500 https://www.lumagroup.com/ 42:12 In this episode, Dr. Themasap Khan sits down with Aeovian Pharmaceuticals' President

and CEO, Dr. Allison Hulme to discuss how she found herself in the pharma

space, what's ahead for Aeovian, and why the work they are doing is so

important for a population with an incredibly high unmet need. We are also

excited to welcome Aeovian and the full team to Luma Group as our most recent

investment (December 2025).

]]> In this episode, Dr. Themasap Khan sits down with Aeovian Pharmaceuticals' President

and CEO, Dr. Allison Hulme to discuss how she found herself in the pharma

space, what's ahead for Aeovian, and why the work they are doing is so

important for a population with an incredibly high unmet need. We are also

excited to welcome Aeovian and the full team to Luma Group as our most recent

investment (December 2025).

]]> false full 7 1 <![CDATA[AI, LABI, and How we Invest: A Conversation with Neel Madhukar, PhD and Themasap Khan, PhD]]> On this episode of IlLUMAnations, we turned inwards for the first time. Co-Founder and Partner of Luma Group, Themasap Khan, PhD, sits down with Neel Madhukar, PhD, Chief Technology Officer of Luma Group’s proprietary AI model, LABI, to discuss the genesis of the program and how it impacts day-to-day processes at Luma Group. Neel and Themasap discuss what we are building at Luma Group to change the game for biotech investing. LABI enables our investors to run deeper and more complex diligence processes, while simultaneously speeding up the process. Neel explains that LABI is an agentic system and therefore able to pull data, graphs, and research while connecting the concepts, allowing our investors to access all the information they need for diligence in minutes.

]]> Mon, 08 Dec 2025 11:34:15 -0500 https://www.lumagroup.com/ 45:15 On this episode of IlLUMAnations, we turned inwards for the first time. Co-Founder and Partner of Luma Group, Themasap Khan, PhD, sits down with Neel Madhukar, PhD, Chief Technology Officer of Luma Group’s proprietary AI model, LABI, to discuss the genesis of the program and how it impacts day-to-day processes at Luma Group. Neel and Themasap discuss what we are building at Luma Group to change the game for biotech investing. LABI enables our investors to run deeper and more complex diligence processes, while simultaneously speeding up the process. Neel explains that LABI is an agentic system and therefore able to pull data, graphs, and research while connecting the concepts, allowing our investors to access all the information they need for diligence in minutes.

]]> On this episode of IlLUMAnations, we turned inwards for the first time. Co-Founder and Partner of Luma Group, Themasap Khan, PhD, sits down with Neel Madhukar, PhD, Chief Technology Officer of Luma Group’s proprietary AI model, LABI, to discuss the genesis of the program and how it impacts day-to-day processes at Luma Group. Neel and Themasap discuss what we are building at Luma Group to change the game for biotech investing. LABI enables our investors to run deeper and more complex diligence processes, while simultaneously speeding up the process. Neel explains that LABI is an agentic system and therefore able to pull data, graphs, and research while connecting the concepts, allowing our investors to access all the information they need for diligence in minutes.

]]> false full 6 1 <![CDATA[Reimagining Chronic Care: A Conversation with Ritish Patnaik of Curve Biosciences]]> In our latest episode of IlLUMAnations, Dr. Themasap Khan, co-founder and partner, sat down with Ritish Patnaik, CEO and co-founder of Curve Biosciences, to discuss his career, the journey to co-founding Curve, the company’s transformative impact, and what’s next. Beyond delving into Curve’s groundbreaking science, Ritish shares leadership insights and advice for navigating the world of biotech, explaining how his life experience pushed him to biotech.

]]> Mon, 01 Dec 2025 16:47:00 -0500 https://www.lumagroup.com/ 50:51 In our latest episode of IlLUMAnations, Dr. Themasap Khan, co-founder and partner, sat down with Ritish Patnaik, CEO and co-founder of Curve Biosciences, to discuss his career, the journey to co-founding Curve, the company’s transformative impact, and what’s next. Beyond delving into Curve’s groundbreaking science, Ritish shares leadership insights and advice for navigating the world of biotech, explaining how his life experience pushed him to biotech.

]]> In our latest episode of IlLUMAnations, Dr. Themasap Khan, co-founder and partner, sat down with Ritish Patnaik, CEO and co-founder of Curve Biosciences, to discuss his career, the journey to co-founding Curve, the company’s transformative impact, and what’s next. Beyond delving into Curve’s groundbreaking science, Ritish shares leadership insights and advice for navigating the world of biotech, explaining how his life experience pushed him to biotech.

]]> false full 5 1 <![CDATA[The New Era of Multi-OMICs Therapy: A Conversation with Cheng Zhang]]> In this episode, Dr. Jamie Kasuboski sits down with Character Biosciences' co-founder and CEO, Cheng Zhang about his career, the journey to co-founding Character Bio and the company’s transformative impact. Cheng also shares leadership insights and advice for navigating the world of biotech.

]]> Tue, 01 Apr 2025 11:53:55 -0400 https://www.lumagroup.com/ 55:48 In this episode, Dr. Jamie Kasuboski sits down with Character Biosciences' co-founder and CEO, Cheng Zhang about his career, the journey to co-founding Character Bio and the company’s transformative impact. Cheng also shares leadership insights and advice for navigating the world of biotech.

]]> In this episode, Dr. Jamie Kasuboski sits down with Character Biosciences' co-founder and CEO, Cheng Zhang about his career, the journey to co-founding Character Bio and the company’s transformative impact. Cheng also shares leadership insights and advice for navigating the world of biotech.

]]> false full 4 1 <![CDATA[Inside the Golden Age of Biotech: A Conversation with Hans Bishop]]> In this episode, Hans Bishop, President, Founder, and Board Co-Chair of Altos Labs, discusses the transformative potential of early cancer detection, the importance of assembling the right team and the evolving landscape of biotech innovations. With over 30 years of experience in the biotechnology industry, Hans shares insights into the future of medicine, the challenges of drug development and the exciting possibilities that lie ahead.


]]> Tue, 18 Feb 2025 14:16:00 -0500 https://www.lumagroup.com/ 40:58 In this episode, Hans Bishop, President, Founder, and Board Co-Chair of Altos Labs, discusses the transformative potential of early cancer detection, the importance of assembling the right team and the evolving landscape of biotech innovations. With over 30 years of experience in the biotechnology industry, Hans shares insights into the future of medicine, the challenges of drug development and the exciting possibilities that lie ahead.


]]> In this episode, Hans Bishop, President, Founder, and Board Co-Chair of Altos Labs, discusses the transformative potential of early cancer detection, the importance of assembling the right team and the evolving landscape of biotech innovations. With over 30 years of experience in the biotechnology industry, Hans shares insights into the future of medicine, the challenges of drug development and the exciting possibilities that lie ahead.


]]> false full 2 1 <![CDATA[Dr. Rosana Kapeller, ROME Therapeutics]]> Dr. Kapeller speaks with Dr. Themasap Khan, PhD and Luma Group Co-Founder, about her path to the biotech industry and leading the development of new approaches to treating serious diseases to unlock the power of the ‘dark genome.’

]]> Tue, 18 Feb 2025 09:00:00 -0500 https://www.lumagroup.com/ 42:49 Dr. Kapeller speaks with Dr. Themasap Khan, PhD and Luma Group Co-Founder, about her path to the biotech industry and leading the development of new approaches to treating serious diseases to unlock the power of the ‘dark genome.’

]]> Dr. Kapeller speaks with Dr. Themasap Khan, PhD and Luma Group Co-Founder, about her path to the biotech industry and leading the development of new approaches to treating serious diseases to unlock the power of the ‘dark genome.’

]]> false full 1 1